Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats.

Abstract

Cellular processes underlying ontogenesis and regression of streptozotocin (STZ)-induced diabetes in newborn rats were investigated at the most severe stage of diabetes at day 3 and after recovery of normoglycemia at day 8 by immunocytochemistry and quantitative analysis. A previously unknown endocrine cell type subpopulation (PEPS) was identified. It was characterized by granule polymorphism, coexpression of insulin and glucagon immunoreactivity, and a proliferative capacity transiently higher than in B cells. In STZ-treated rats at day 3, B cell mass decreased 14-fold, whereas PEPS cells were unaffected. The islet mass was restored to 55.7% by day 8, with a concomitant appearance of numerous small islets contiguous to small ducts. B cell mass increased by 6.9-fold compared with 1.8-fold in control rats, although proliferative capacities remained similar. Proliferation dropped considerably by day 8, preventing complete B cell mass recovery in STZ-treated rats. STZ-induced neonatal diabetes thus stimulates neogenesis of islets close to ducts and proliferation of PEPS cells. Those partially differentiated islet cells appear to be on the differentiation pathway of stem cells to fully differentiated B cells.

Statistics

0204060'98'00'02'04'06'08'10'12'14'16
Citations per Year

110 Citations

Semantic Scholar estimates that this publication has 110 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ferrand1995DynamicsOP, title={Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats.}, author={Nathalie Ferrand and A. Astesano and H H Phan and Christine Lelong and Gabriel E. Rosselin}, journal={The American journal of physiology}, year={1995}, volume={269 5 Pt 1}, pages={C1250-64} }